Pancreatic Adenocarcinoma Metastatic
Oncology
2 drugs in development·1 company·6 clinical trials
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| Niraparib | IGM Biosciences, Inc. (IGMS) |
Phase 1(1)
| Drug | Company |
|---|---|
| FOLFIRI | IGM Biosciences, Inc. (IGMS) |
Compare drugs
Frequently asked questions
How many drugs are in development for Pancreatic Adenocarcinoma Metastatic?
BioSniper tracks 2 drugs in development for Pancreatic Adenocarcinoma Metastatic across 1 company.
How many clinical trials target Pancreatic Adenocarcinoma Metastatic?
There are 6 clinical trials targeting Pancreatic Adenocarcinoma Metastatic tracked by BioSniper.
Deep-dive into Pancreatic Adenocarcinoma Metastatic
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis